NCT00275236
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Schwarz BioSciences Monheim, Germany
Clinical trial condition
Restless Legs Syndrome
Explore clinical trials studying Restless Legs Syndrome. Study availability and eligibility vary by location and protocol.
199 public trials
20 recruiting studies
Restless Legs Syndrome trial results
Completed
Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
NCT00498108
- Conditions
- Dyssomnias, Idiopathic Restless Legs Syndrome, Mental Disorders, +5 more
- Locations
-
- Kassel, Germany
Completed
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
NCT00135993
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Schwarz RTP, North Carolina, United States
NCT02248142
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
Not specified
Completed
Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome
NCT00136045
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Schwarz Monheim, Germany
NCT01174459
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site 119 Akashi, Japan
- Boehringer Ingelheim Investigational Site 52 Akishima, Japan
- Boehringer Ingelheim Investigational Site 16 Akita, Japan
- Boehringer Ingelheim Investigational Site 22 Ami-machi, Japan
NCT01569464
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- 006 Birmingham, Alabama, United States
- 013 Jasper, Alabama, United States
- 021 Gilbert, Arizona, United States
- 014 Little Rock, Arkansas, United States
NCT00887289
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site Aalen, Germany
- Boehringer Ingelheim Investigational Site 1 Achim, Germany
- Boehringer Ingelheim Investigational Site 2 Achim, Germany
- Boehringer Ingelheim Investigational Site 1 Ahrensburg, Germany
NCT00472199
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- 248.629.4302 Boehringer Ingelheim Investigational Site Innsbruck, Austria
- 248.629.4304 Boehringer Ingelheim Investigational Site Linz, Austria
- 248.629.3201 Boehringer Ingelheim Investigational Site Edegem, Belgium
- 248.629.35801 Boehringer Ingelheim Investigational Site Espoo, Finland
NCT00654498
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- 248.630.04 Boehringer Ingelheim Investigational Site Beijing, China
- 248.630.05 Boehringer Ingelheim Investigational Site Beijing, China
- 248.630.06 Boehringer Ingelheim Investigational Site Beijing, China
- 248.630.07 Boehringer Ingelheim Investigational Site Beijing, China